Agios Pharmaceuticals Inc. buy Truist Financial Co.
Start price
30.04.26
/
50%
€24.00
Target price
30.04.27
€30.85
Performance (%)
50.83%
Price
10.07.26
€36.20
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ for Agios Pharmaceuticals Inc. has seen massive gains of 50.83%. This prediction currently runs until 30.04.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Agios Pharmaceuticals Inc. | 10.366% | 10.366% |
| iShares Core DAX® | -2.680% | 2.021% |
| iShares Nasdaq 100 | 0.725% | 2.753% |
| iShares Nikkei 225® | -0.725% | 5.698% |
| iShares S&P 500 | 1.166% | 4.063% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals (AGIO) had its price target lowered by Truist Financial Corporation from $39.00 to $36.00. They now have a "buy" rating on the stock.
Ratings data for AGIO provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€33.60
07.07.26
07.07.26
€35.85
07.07.27
07.07.27
7.74%
10.07.26
10.07.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.80
24.12.25
24.12.25
€32.19
24.12.26
24.12.26
52.10%
10.07.26
10.07.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.00
24.11.25
24.11.25
-
24.11.26
24.11.26
57.39%
10.07.26
10.07.26